CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.28 ($1,400)
- 4 Open-market buy Director bought 100,000 shares at $0.41 ($41,000)
- 4 Open-market buy Director bought 4,000 shares at $1.48 ($5,920)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.88 ($9,400)
- 4 Open-market buy Director bought 31,078 shares at an average $3.09 ($96,141)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion 10% owner acquired 1,648,289 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,648,289 shares (option exercise)
- 4 Exercise or conversion Director acquired 350,853 shares (option exercise)
- 4 Open-market sale 10% owner sold 998,204 shares at an average $0.16 ($158,772)
- 4 Open-market buy Director bought 230,768 shares
- 4 Open-market buy 10% owner bought 538,460 shares
- 4 Open-market buy Director bought 538,460 shares
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 15 · 288 filings